OPTIMA is a consortium of clinicians and researchers pioneering Precision Medicine in India through enabling genomic understanding of suboptimal therapeutic response.

What is OPTIMA
Omics for Precise Therapeutic Interventions Minimising Adverse Events (OPTIMA) is a research collaboration aimed at pioneering Precision Medicine in India through enabling genomic understanding of sub-optimal therapeutic response. [more]

Collaborating with OPTIMA
If you are a Clinician or Researcher, you could collaborate with the OPTIMA network and participate in ongoing research initiatives. [more]



Clinical and Research Programmes
We are presently implementing a number of clinical and research programmes which enable Precision medicine in various specialty areas. The programmes are targeted at specific needs 


Recently in News

  • QATAR EXOME STUDY: AN ADVANCEMENT IN PRECISION MEDICINE By Louise Sarant .Scientists look at Qataris' exome sequences to anticipate response to two common blood-thinnersThe study, by a team from the Delhi-based CSIR Institute of Genomics ...
    Posted Apr 22, 2017, 5:04 AM by Vinod Scaria
Showing posts 1 - 1 of 1. View more »

Upcoming Events

  • Genomics for Clinicians / Tirunelveli Medical College Workshop on the concept and application of genomics in clinical medicine Genomic technologies have been progressing at break-neck speed in the recent years, with newer applications being developed almost ...
    Posted Apr 22, 2017, 7:18 AM by Vinod Scaria
Showing posts 1 - 1 of 1. View more »

Recent Publications

  • Landscape of warfarin and clopidogrel pharmacogenetic variants in Qatari population from whole exome datasets Pharmacogenetic landscapes of commonly used antiplatelet drugs, warfarin and clopidogrel have been studied in-depth in many countries. However, there is a paucity of data to understand their patterns in ...
    Posted Apr 23, 2017, 2:44 AM by Vinod Scaria
  • Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole genome sequences Expanding the scope of pharmacogenomic research by including multiple global populations is integral to building robust evidence for its clinical translation. Deep whole-genome sequencing of diverse ethnic populations provides ...
    Posted Oct 4, 2016, 5:26 AM by Vinod Scaria
Showing posts 1 - 2 of 4. View more »